Skip to main content
. Author manuscript; available in PMC: 2021 Oct 1.
Published in final edited form as: Am J Transplant. 2020 Apr 26;20(10):2768–2780. doi: 10.1111/ajt.15863

TABLE 2.

Patient demographics

Multicenter adult
Single-center adult
Patients No rejection n = 59 Rejection n = 56 P-value No rejection n = 21 Rejection n = 42 P-value
Age (y), mean ± SD 52 ± 11 51 ± 11 .43 50 ± 14 50 ± 12 .91
Sex (male), n (%) 47 (80) 46 (82) .82 15 (71) 29 (69) .99
Race
 White, n (%) 37 (63) 46 (82) .04 12 (57) 25 (60) .06
End-stage disease, n (%)
 Idiopathic cardiomyopathy 25 (42) 28 (50) .27 7 (33) 15 (36) .99
 Coronary artery disease 12 (20) 14 (25) 0 1 (2)
 Congenital heart disease 0 (0) 1 (2) 2 (10) 3 (7)
 Myocarditis 0 (0) 1 (2) 0 1 (2)
 Valvular heart disease 1 (2) 0 (0) 0 0
 Other etiology 21 (36) 12 (21) 12 (57) 22 (52)
Induction therapy, n (%) 15 (25) 19 (34) .41 5 (24) 11 (26) .73
Mechanical circulatory support, n (%) 14 (24) 15 (27) .08 9 (43) 11 (26) .25
HLA-A, -B, -DR mismatches ≥3, n/total (%) 53/55 (96) 45/48 (94) .66 20/21 (95) 42/42 (100) .44